In this captivating episode, David engages in a thought-provoking conversation with none other than Joshua White, the visionary CEO behind the Fireside Project. This groundbreaking initiative has ushered in a new era of support and safety within the realm of psychedelics, as it introduces the world's first real-time psychedelic peer support line.
Similar Posts
Interview With Josh Bartch, Mydecine Innovations Group
Global Trac Solutions, Inc. CEO, David Flores sits down to speak with Co-Founder & CEO, of Mydecine Innovations Group, Josh Bartch.
MindMed Patents 18MC? A new Psychedelic ETF? [ Plus more MMED/MMEDF, LOBE, CYBIN & COOL Updates]
In today’s episode of “This Week in Psychedelic Stocks”, we have News on MindMed (MMED / MMEDF/MMQ), Compass Pathways (CMPS), Cybin (CYBN) , Core One Labs ( COOL) & Lobe Sciences (LOBE).
I covered some breaking news on MindMed yesterday in our impromptu episode on the MindMed stock being added to the FTSE so that MMED / MMEDF news is not in this episode. However, this wasn’t the only big news this week. Compass Pathways (CMPS) received not one but 2 new patents and surely, some of you might find this news worth discussing…
We will cover the latest developments in the field writ large.
This means we will cover any stories that affect the all the companies in this field, as well as company specific developments.
Timestamps:
0:00 – Intro
1:18 – New Psychedelic ETF (PSIL)
5:44 – Baltimore decriminalizes the possession of all drugs
6:53 – Hawaii to study the benefits of psilocybin
8:29 – Harvard University to study psychedelics
9:42 – UCSF also decides to study psychedelics
11:24 – MindMed (MMED / MMEDF / MMQ) announced the company’s 2020 End-Year Financial results + link 12:32 on video end year
12:50 – MindMed files F10 File with the SEC ( important step before uplisting to the NASDAQ)
14:11 – MindMed’s 2020 conference call highlights
15:06 – MindMed (MMED) has now filed a patent application for its 18-MC compound
17:04 – Cybin (CYBN / CLXPF) management restructuring
19:40 – Core One Labs (COOL ) stock updates
20:48 – Lobe Sciences ( Lobe) company updates
So that’s it for This Week in Psychedelic Stocks fellow psychedelic investors!
I hope you guys found some value in this and I’ll keep you posted for more changes!
Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!
Follow us on social media! 🙌
Instagram: @psychedelicinvestor
email: thepsychedelicinvestor@gmail.com
Facebook: @thepsychedelicinvestor
Music: www.bensound.com
https://benzinga.grsm.io/jameshallifa…
https://benzinga.grsm.io/thepsychedel…
DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.
#MindMed #MMED #MindMedStock
Interview With Payton Nyquvest
In this episode of the Psychedelic Spotlight podcast, Global Trac Solutions, Inc. CEO, David Flores, sits down with Payton Nyquvest, CEO and Chairman of Numinus Wellness, Inc.
Ask A Psychedelic Guide
We welcome back Nick Levich for our “Ask a Psychedelic Professional” series and as part of our “Ask a Psychedelic Guide” episode.
Amanita Muscaria and Desert Herbalism with Ash Ritter
We dive into the world of the infamous Amanita Muscaria mushroom and learn about the wild desert apothecary of fungi and herbs.
‘Right To Try Laws’ and Legal Access to Psilocybin Therapy with Dr. Jonathan Fields
Petitioning the DEA to respect the ‘Right to Try Laws’ which empower terminally ill patients to legally access psilocybin therapy.